Table 3. Overweight+obese vs normal weight: multivariant analyses including age, tumour stage, nodal stage, tumour grade, and ER and PR expression.
|
All |
3 years Anastrozole |
No treatment |
||||
|---|---|---|---|---|---|---|
| HR | 95% CI | HR | 95% CI | HR | 95% CI | |
|
DFS | ||||||
| Overweight+obese vs Normal weight |
0.89 |
0.55–1.12 |
1.27 |
0.65–2.46 |
0.68 |
0.42–1.10 |
|
Distant recurrence-free survival | ||||||
| Overweight+obese vs Normal weight |
1.29 |
0.61–2.76 |
3.41 |
0.74–15.75 |
0.79 |
0.33–1.97 |
|
Overall survival | ||||||
| Overweight+obese vs Normal weight | 0.77 | 0.49–1.28 | 0.71 | 0.27–1.86 | 0.67 | 0.34–1.35 |
Abbreviations: CI=confidence interval; DFS=disease-free survival; HR=hazard ratio.